Dermatological Disorders

ERIVEDGE (vismodegib) 150mg capsules by Genentech

Erivedge Approved for Advanced Basal Cell Carcinoma

Genentech announced that the FDA has approved Erivedge (vismodegib capsules) for the treatment of adults with advanced basal cell carcinoma (BCC), that has spread to other parts of the body or that has come back after surgery or that their healthcare provider decides cannot be treated with surgery or radiation.

Hylase Wound Gel Available

Hi-Tech Pharmacal and its subsidiary ECR Pharmaceuticals announced the launch of Hylase Wound Gel for the management and treatment of leg ulcers, pressure ulcers, diabetic ulcers, and exuding wounds prone to bleeding.